Artesunate vaginal inserts for high-grade cervical changes
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This Phase 2 study tests whether artesunate vaginal inserts can help treat high-grade abnormal cells on the cervix (CIN2/3). It’s meant for adults who have a confirmed high-grade precancer change and can use birth control during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult woman age 25 or older.
- You can sign informed consent and understand what the study involves.
- Your biopsy (tissue sample) must confirm high-grade cervical changes (CIN2, CIN3, or CIN2/3).
- Your HPV test can show any HPV type (not limited to one specific type).
- If you could become pregnant, you must use birth control through week 17, and you must be at least 50 kg.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artesunate ointment for women with high-grade vulvar lesions caused by HPV. It aims to see if the ointment can help the lesions heal or disappear without needing surgery.
This trial tests an oral medication called artesunate to see if it can help treat cervical precancer (CIN2/3) caused by HPV. It is a possible option for women who are newly diagnosed and have not had this condition before.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This study tests whether a vaginal gel can help early cervical cell changes (CIN1 or CIN2) go away on their own and clear the HPV virus. If you are being monitored without treatment, this gel might increase your chances of recovery.
Hear when a new CIN 2/3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.